PFS Partners’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-340
| Closed | -$1.03K | – | 518 |
|
|
2025
Q1 | $1.03K | Hold |
340
| – | – | ﹤0.01% | 407 |
|
|
2024
Q4 | $1.23K | Hold |
340
| – | – | ﹤0.01% | 410 |
|
|
2024
Q3 | $599 | Hold |
340
| – | – | ﹤0.01% | 422 |
|
|
2024
Q2 | $531 | Hold |
340
| – | – | ﹤0.01% | 413 |
|
|
2024
Q1 | $663 | Hold |
340
| – | – | ﹤0.01% | 432 |
|
|
2023
Q4 | $480 | Sell |
340
-60
| -15% | -$85 | ﹤0.01% | 433 |
|
|
2023
Q3 | $632 | Hold |
400
| – | – | ﹤0.01% | 436 |
|
|
2023
Q2 | $864 | Sell |
400
-6
| -1% | -$13 | ﹤0.01% | 448 |
|
|
2023
Q1 | $853 | Hold |
406
| – | – | ﹤0.01% | 361 |
|
|
2022
Q4 | $890 | Hold |
406
| – | – | ﹤0.01% | 348 |
|
|
2022
Q3 | $1.22K | Hold |
406
| – | – | ﹤0.01% | 333 |
|
|
2022
Q2 | $1.15K | Hold |
406
| – | – | ﹤0.01% | 329 |
|
|
2022
Q1 | $2.17K | Hold |
406
| – | – | ﹤0.01% | 307 |
|
|
2021
Q4 | $3.03K | Buy |
+406
| New | +$3.03K | ﹤0.01% | 289 |
|